The Global Cardiac Biomarkers Market is driven by the rising prevalence of cardiovascular diseases, demanding rapid, accurate diagnostics. Opportunities lie in technological advancements in biomarker ...

Most clinicians in the US see lipoprotein A (Lp [a]) as a useful tool in cardiovascular risk stratification, according to a new survey. However, the respondents were less certain about what to do with ...

The BNP and NTproBNP market growth is driven by rising cardiovascular diseases and an aging population. Opportunities lie in enhancing point-of-care diagnostics to improve early detection and ...

Please provide your email address to receive an email when new articles are posted on . Many adult survivors of childhood cancer are not regularly screened for cardiovascular disease. Primary ...

Experts discuss atherosclerotic cardiovascular disease and aortic stenosis, as well as their burden, highlighting their prevalence, impact on patient health, and the growing need for effective ...

Researchers at Keele University have said that more targeted use of testing for a common molecule could help to improve predictions of cardiovascular disease outcomes in patients at greatest risk. The ...

Series of studies will focus on genetic drivers of cardiovascular disease, and how data can improve care, especially in underserved communities SAN DIEGO, April 11, 2023 /PRNewswire/ -- Illumina Inc. ...

A remarkable breakthrough, a collaborative team of researchers, led by Professor Yaakov Nahmias from The Hebrew University of Jerusalem, Technion-Israel Institute of Technology, and Tissue Dynamics ...

ALISO VIEJO, Calif.--(BUSINESS WIRE)--Ambry Genetics (“Ambry”) announces the launch of powerful cardiovascular genetic testing panels for inherited cardiomyopathies and arrhythmias. These feature an ...